Ghatnekar GS - Search Results

1

Novel therapies for scar reduction and regenerative healing of skin wounds.

Rhett JM, Ghatnekar GS, Palatinus JA, O'Quinn M, Yost MJ, Gourdie RG. Rhett JM, et al. Among authors: ghatnekar gs. Trends Biotechnol. 2008 Apr;26(4):173-80. doi: 10.1016/j.tibtech.2007.12.007. Epub 2008 Mar 4. Trends Biotechnol. 2008. PMID: 18295916 Review.

2

The unstoppable connexin43 carboxyl-terminus: new roles in gap junction organization and wound healing.

Gourdie RG, Ghatnekar GS, O'Quinn M, Rhett MJ, Barker RJ, Zhu C, Jourdan J, Hunter AW. Gourdie RG, et al. Among authors: ghatnekar gs. Ann N Y Acad Sci. 2006 Oct;1080:49-62. doi: 10.1196/annals.1380.005. Ann N Y Acad Sci. 2006. PMID: 17132774 Review.

3

Connexin43 carboxyl-terminal peptides reduce scar progenitor and promote regenerative healing following skin wounding.

Ghatnekar GS, O'Quinn MP, Jourdan LJ, Gurjarpadhye AA, Draughn RL, Gourdie RG. Ghatnekar GS, et al. Regen Med. 2009 Mar;4(2):205-23. doi: 10.2217/17460751.4.2.205. Regen Med. 2009. PMID: 19317641 Free PMC article.

4

A Connexin43 Mimetic Peptide Promotes Regenerative Healing and Improves Mechanical Properties in Skin and Heart.

Ongstad EL, O'Quinn MP, Ghatnekar GS, Yost MJ, Gourdie RG. Ongstad EL, et al. Among authors: ghatnekar gs. Adv Wound Care (New Rochelle). 2013 Mar;2(2):55-62. doi: 10.1089/wound.2011.0341. Adv Wound Care (New Rochelle). 2013. PMID: 24527326 Free PMC article. Review.

5

Cardiac to cancer: connecting connexins to clinical opportunity.

Grek CL, Rhett JM, Ghatnekar GS. Grek CL, et al. Among authors: ghatnekar gs. FEBS Lett. 2014 Apr 17;588(8):1349-64. doi: 10.1016/j.febslet.2014.02.047. Epub 2014 Mar 4. FEBS Lett. 2014. PMID: 24607540 Free PMC article. Review.

6

The effect of a connexin43-based Peptide on the healing of chronic venous leg ulcers: a multicenter, randomized trial.

Ghatnekar GS, Grek CL, Armstrong DG, Desai SC, Gourdie RG. Ghatnekar GS, et al. J Invest Dermatol. 2015 Jan;135(1):289-298. doi: 10.1038/jid.2014.318. Epub 2014 Jul 29. J Invest Dermatol. 2015. PMID: 25072595 Free PMC article. Clinical Trial.

7

Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.

Grek CL, Prasad GM, Viswanathan V, Armstrong DG, Gourdie RG, Ghatnekar GS. Grek CL, et al. Among authors: ghatnekar gs. Wound Repair Regen. 2015 Mar-Apr;23(2):203-12. doi: 10.1111/wrr.12275. Epub 2015 Apr 29. Wound Repair Regen. 2015. PMID: 25703647 Free PMC article. Clinical Trial.

8

Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1.

Grek CL, Rhett JM, Bruce JS, Abt MA, Ghatnekar GS, Yeh ES. Grek CL, et al. Among authors: ghatnekar gs. BMC Cancer. 2015 Apr 3;15:296. doi: 10.1186/s12885-015-1229-6. BMC Cancer. 2015. PMID: 25881004 Free PMC article.

9

Connexin 43, breast cancer tumor suppressor: Missed connections?

Grek CL, Rhett JM, Bruce JS, Ghatnekar GS, Yeh ES. Grek CL, et al. Among authors: ghatnekar gs. Cancer Lett. 2016 Apr 28;374(1):117-126. doi: 10.1016/j.canlet.2016.02.008. Epub 2016 Feb 13. Cancer Lett. 2016. PMID: 26884256 Review.

10

A Multicenter Randomized Controlled Trial Evaluating a Cx43-Mimetic Peptide in Cutaneous Scarring.

Grek CL, Montgomery J, Sharma M, Ravi A, Rajkumar JS, Moyer KE, Gourdie RG, Ghatnekar GS. Grek CL, et al. Among authors: ghatnekar gs. J Invest Dermatol. 2017 Mar;137(3):620-630. doi: 10.1016/j.jid.2016.11.006. Epub 2016 Nov 14. J Invest Dermatol. 2017. PMID: 27856288 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page